Showing results (1-10 of 14) with videos related to
Sort By:
Pageof 2
American Journal of Hospital Pharmacy|September 1, 1978
Use of a programmable calculator to determine steady-state levels of drugs eliminated by parallel first-order and Michaelis-Menten kineticsJ W Crow, G LevyJournal of Pharmaceutical Sciences|October 1, 1979
Comparative pharmacokinetics of coumarin anticoagulants. XLII: Effect of phenobarbital on systemic availability of orally administered dicumarol in rats with ligated bile ductsJ W Crow, M Gibaldi, G LevyJournal of Pharmacokinetics and Biopharmaceutics|December 1, 1980
Pitfalls and valid approaches to pharmacokinetic analysis of mean concentration data following intravenous administrationD M Cocchetto, W A Wargin, J W CrowClinical Pharmacology and Therapeutics|August 1, 1981
Effects of prostacyclin infusion in uremic patients: hematologic and hemodynamic responsesR M Zusman, J W Crow, A E Cato, et al.Clinical Pharmacology and Therapeutics|October 1, 1977
Glutethimide and 4-OH glutethimide: pharmacokinetics and effect on performance in manJ W Crow, P Lain, F Bochner, et al.Journal of Clinical Pharmacology|September 1, 1988
Epoprostenol (PGI2, prostacyclin) during high-risk hemodialysis: preventing further bleeding complicationsR D Swartz, W Flamenbaum, A Dubrow, et al.Blood Purification|January 1, 1991
Controlled study of heparin versus epoprostenol sodium (prostacyclin) as the sole anticoagulant for chronic hemodialysisR J Caruana, M C Smith, D Clyne, et al.The New England Journal of Medicine|April 16, 1981
Hemodialysis using prostacyclin instead of heparin as the sole antithrombotic agentR M Zusman, R H Rubin, A E Cato, et al.The American Journal of Medicine|November 1, 1982
Prostacyclin substitution for heparin in long-term hemodialysisM C Smith, K Danviriyasup, J W Crow, et al.Ophthalmology|March 1, 1981
Effect of synthetic cannabinoids on elevated intraocular pressureJ S Tiedeman, M B Shields, P A Weber, et al.Pageof 2